| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |